Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.0%

2 terminated out of 25 trials

Success Rate

80.0%

-6.6% vs benchmark

Late-Stage Pipeline

16%

4 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed with results

Key Signals

3 with results80% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (12)
P 1 (2)
P 3 (2)
P 4 (2)

Trial Status

Completed8
Recruiting8
Unknown4
Terminated2
Withdrawn2
Not Yet Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.6%

Based on 8 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07541404Not ApplicableRecruitingPrimary

MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma

NCT07712198Completed

Al Prediction of Sarcopenia Risk in Neurocritical ICU Patients

NCT07822724Not Yet Recruiting

Outcomes of Traumatic Intracranial Hemorrhage in the Elderly

NCT07656818Not ApplicableRecruiting

Non-Thermal Plasma to Reduce Recurrence in Chronic Subdural Hematoma

NCT05713630Phase 3RecruitingPrimary

The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma

NCT07258069RecruitingPrimary

Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)

NCT06724029Recruiting

Neurosurgical Outcome Network

NCT04923984Not ApplicableRecruitingPrimary

Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)

NCT04402632Not ApplicableCompletedPrimary

Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma

NCT07143799Not ApplicableRecruitingPrimary

Scalp Block Versus General Anesthesia in Patients Undergoing Evacuation of Subdural Hematoma Via Burr Hole

NCT06067750Completed

Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation

NCT05649904Not ApplicableRecruiting

AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis

NCT05472766Not ApplicableTerminatedPrimary

Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma

NCT04270955Not ApplicableCompleted

Dartmouth Middle Meningeal Embolization Trial (DaMMET)

NCT04500795Not ApplicableWithdrawn

Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma

NCT06119932UnknownPrimary

Evaluation of One Burr Hole Evacuation for Subdural Hematoma

NCT06052124Not ApplicableUnknownPrimary

Augmented Reality for Subdural Drain Placement

NCT04170582Unknown

Patient Registry for Patients With Chronic Subdural Hematoma

NCT03153150Phase 3Completed

Start or STop Anticoagulants Randomised Trial (SoSTART)

NCT02618382Phase 4CompletedPrimary

A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population

Scroll to load more

Research Network

Activity Timeline